Furthermore, apremilast improves oxidized low-density lipoprotein-induced endothelial dysfunction via the rescue of Krüppel like factor-6 expression, suggesting a potential role for apremilast in the treatment of atherosclerotic cardiovascular disease (Figure 2) [27]. The gene discussed is KLF6; the disease is endothelial dysfunction.